174 related articles for article (PubMed ID: 19934329)
1. Embryonic lethality after combined inactivation of Fancd2 and Mlh1 in mice.
van de Vrugt HJ; Eaton L; Hanlon Newell A; Al-Dhalimy M; Liskay RM; Olson SB; Grompe M
Cancer Res; 2009 Dec; 69(24):9431-8. PubMed ID: 19934329
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses.
Peng M; Xie J; Ucher A; Stavnezer J; Cantor SB
EMBO J; 2014 Aug; 33(15):1698-712. PubMed ID: 24966277
[TBL] [Abstract][Full Text] [Related]
3. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.
Houghtaling S; Timmers C; Noll M; Finegold MJ; Jones SN; Meyn MS; Grompe M
Genes Dev; 2003 Aug; 17(16):2021-35. PubMed ID: 12893777
[TBL] [Abstract][Full Text] [Related]
4. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.
Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M
Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282
[TBL] [Abstract][Full Text] [Related]
5. Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
Basu M; Mukhopadhyay D; Chakraborty B; Ghosh S; Pal DK; Ghosh A; Panda CK
Mol Cell Biochem; 2023 Jul; 478(7):1599-1610. PubMed ID: 36434146
[TBL] [Abstract][Full Text] [Related]
6. Functional and physical interaction between the mismatch repair and FA-BRCA pathways.
Williams SA; Wilson JB; Clark AP; Mitson-Salazar A; Tomashevski A; Ananth S; Glazer PM; Semmes OJ; Bale AE; Jones NJ; Kupfer GM
Hum Mol Genet; 2011 Nov; 20(22):4395-410. PubMed ID: 21865299
[TBL] [Abstract][Full Text] [Related]
7. FANCD2 binds CtIP and regulates DNA-end resection during DNA interstrand crosslink repair.
Unno J; Itaya A; Taoka M; Sato K; Tomida J; Sakai W; Sugasawa K; Ishiai M; Ikura T; Isobe T; Kurumizaka H; Takata M
Cell Rep; 2014 May; 7(4):1039-47. PubMed ID: 24794430
[TBL] [Abstract][Full Text] [Related]
8. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
Reliene R; Yamamoto ML; Rao PN; Schiestl RH
Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
[TBL] [Abstract][Full Text] [Related]
9. Tip60 is required for DNA interstrand cross-link repair in the Fanconi anemia pathway.
Hejna J; Holtorf M; Hines J; Mathewson L; Hemphill A; Al-Dhalimy M; Olson SB; Moses RE
J Biol Chem; 2008 Apr; 283(15):9844-51. PubMed ID: 18263878
[TBL] [Abstract][Full Text] [Related]
10. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of Uaf1 causes defective homologous recombination and early embryonic lethality in mice.
Park E; Kim JM; Primack B; Weinstock DM; Moreau LA; Parmar K; D'Andrea AD
Mol Cell Biol; 2013 Nov; 33(22):4360-70. PubMed ID: 24001775
[TBL] [Abstract][Full Text] [Related]
12. Severe Fanconi Anemia phenotypes in Fancd2 depletion mice.
Yang Q; Xie H; Zhong Y; Li D; Ke X; Ying H; Yu B; Zhang T
Biochem Biophys Res Commun; 2019 Jun; 514(3):713-719. PubMed ID: 31078270
[TBL] [Abstract][Full Text] [Related]
13. Human MLH1 protein participates in genomic damage checkpoint signaling in response to DNA interstrand crosslinks, while MSH2 functions in DNA repair.
Wu Q; Vasquez KM
PLoS Genet; 2008 Sep; 4(9):e1000189. PubMed ID: 18787700
[TBL] [Abstract][Full Text] [Related]
14. Mammalian SNM1 is required for genome stability.
Hemphill AW; Bruun D; Thrun L; Akkari Y; Torimaru Y; Hejna K; Jakobs PM; Hejna J; Jones S; Olson SB; Moses RE
Mol Genet Metab; 2008 May; 94(1):38-45. PubMed ID: 18180189
[TBL] [Abstract][Full Text] [Related]
15. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin.
Montes de Oca R; Andreassen PR; Margossian SP; Gregory RC; Taniguchi T; Wang X; Houghtaling S; Grompe M; D'Andrea AD
Blood; 2005 Feb; 105(3):1003-9. PubMed ID: 15454491
[TBL] [Abstract][Full Text] [Related]
16. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.
Gallmeier E; Hucl T; Calhoun ES; Cunningham SC; Bunz F; Brody JR; Kern SE
Cancer Biol Ther; 2007 May; 6(5):654-60. PubMed ID: 17387268
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
18. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage.
Ohashi A; Zdzienicka MZ; Chen J; Couch FJ
J Biol Chem; 2005 Apr; 280(15):14877-83. PubMed ID: 15671039
[TBL] [Abstract][Full Text] [Related]
19. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells.
Otsuki T; Wang J; Demuth I; Digweed M; Liu JM
Int J Hematol; 1998 Apr; 67(3):243-8. PubMed ID: 9650445
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of UBE2T, the E2Â Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia.
Rickman KA; Lach FP; Abhyankar A; Donovan FX; Sanborn EM; Kennedy JA; Sougnez C; Gabriel SB; Elemento O; Chandrasekharappa SC; Schindler D; Auerbach AD; Smogorzewska A
Cell Rep; 2015 Jul; 12(1):35-41. PubMed ID: 26119737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
